Unknown

Dataset Information

0

Screening for pharmacological chaperones in Fabry disease.


ABSTRACT: As a prerequisite for clinical trials of pharmacological chaperone therapy (PCT) for Fabry disease, we developed a rapid screening assay for enhancement of endogenous alpha-galactosidase A (alpha-Gal A) in patient-derived cells. We used a T-cell based system to screen 11 mutations causing Fabry disease for enhanceability using 1-deoxygalactonojirimycin (DGJ). When patient-derived T-cells were grown in the presence of DGJ, alpha-Gal A activity increased to more than 50% of normal in several mutations but was unaffected in others. In addition to the mutation R301Q, reported previously, A97V, R112H, R112C, A143T, and L300P were enhanceable, but R356W, G132R, A143P, R220X, and 30delG were not. The level of alpha-Gal A activity achieved provides a basis for the therapeutic trial of DGJ in patients with similarly enhanceable enzyme. This assay method has general utility in other disorders in assessing the degree of enhancement of activity of mutated proteins by PCT.

SUBMITTER: Shin SH 

PROVIDER: S-EPMC2729584 | biostudies-literature | 2007 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Screening for pharmacological chaperones in Fabry disease.

Shin Sang-Hoon SH   Murray Gary J GJ   Kluepfel-Stahl Stefanie S   Cooney Adele M AM   Quirk Jane M JM   Schiffmann Raphael R   Brady Roscoe O RO   Kaneski Christine R CR  

Biochemical and biophysical research communications 20070522 1


As a prerequisite for clinical trials of pharmacological chaperone therapy (PCT) for Fabry disease, we developed a rapid screening assay for enhancement of endogenous alpha-galactosidase A (alpha-Gal A) in patient-derived cells. We used a T-cell based system to screen 11 mutations causing Fabry disease for enhanceability using 1-deoxygalactonojirimycin (DGJ). When patient-derived T-cells were grown in the presence of DGJ, alpha-Gal A activity increased to more than 50% of normal in several mutat  ...[more]

Similar Datasets

| S-EPMC3216245 | biostudies-literature
| S-EPMC8699827 | biostudies-literature
| S-EPMC3729670 | biostudies-literature
| S-EPMC9105905 | biostudies-literature
| S-EPMC5082870 | biostudies-literature
| S-EPMC4445328 | biostudies-literature
| S-EPMC7914515 | biostudies-literature
| S-EPMC5031207 | biostudies-literature
| S-EPMC1989145 | biostudies-literature
| S-EPMC10299185 | biostudies-literature